HALISTER1: INDIA RATINGS: Bafna Pharmaceuticals, GKC Projects Cut

INDIA RATINGS: Bafna Pharmaceuticals, GKC Projects Cut

(Bloomberg) -- Here’s a roundup of Indian co. debt-rating changes.
  • To get this story sent to your inbox real-time, run NI INRATINGS , click on Display & Edit, then Set Alert Delivery
DOWNGRADES
  • Bafna Pharmaceuticals
    • Long-term rating cut to D from Crisil
    • Cites delays in servicing term loan obligations in November and December
  • GKC Projects
    • LT rating cut to D from BB- at ICRA
    • Cites delays in debt servicing by company
Alert: HALISTER1
Source: BFW (Bloomberg First Word)

Tickers
BFNA IN (Bafna Pharmaceuticals Ltd)

To de-activate this alert, click here

UUID: 7947283

HALISTER1: DBRS Canadian University Peer Comparison Table

DBRS Canadian University Peer Comparison Table

Alert: HALISTER1
Source: DBR (Dominion Bond Rating Service)

Tickers
3717Z CN (Brock University)
340973Z US (Concordia University/Canada)
523812Z CN (McMaster University)
85025MF US (Ottawa University)
2751172Z CN (Queen's University)

People
Brenda Lum (DBRS Ltd)
Travis Shaw (DBRS Ltd)

Topics
Credit Analysis Research
Credit Research
Fixed Income Research
Investment Research
Prov., Reg. Credit Research

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283